Atrion (ATRI) Inventory Turnover Ratio, from second quarter 2024 to second quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Atrion Corporation  (NASDAQ: ATRI)
 

Atrion Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Atrion Corporation inventory turnover ratio, the Atrion Corporation's ability to sell and replace its inventory in the second quarter 2024, sequentially increased to 0.24 in the second quarter 2024, yet the ratio remained below the average, as ATRI's market remain challenging.Average inventory processing period, for the Atrion in Jun 30 2024 quarter, has decreased to 1521 days, compare to 2433 days, in the Mar 31 2024 quarter.

Within Healthcare sector 407 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2024, to 1184, from total ranking in the first quarter 2024 at 1196.

ATRI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Atrion Corporation Market Share?

What is Inventory Turnover Ratio?




ATRI Inventory Turnover Ratio (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Inventory Growth -15.71 % -0.12 % 25.1 % 39.12 % 47.85 %
Y / Y Cost of Sales Growth 23.86 % 40.43 % - 4.44 % -5.22 %
Inventory Turnover Ratio (TTM) 0.24 0.15 - 1.37 1.47
ATRI's Total Ranking # 1184 # 1196 # 893 # 1428 #
Average inventory processing period 1501 2364 - 266 248
Seq. Inventory Growth -9.81 % -8.88 % -0.77 % 3.36 % 6.87 %
Seq. Cost of Sales Growth -5.88 % - - 5.98 % 6.71 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 177
Healthcare Sector # 408
Overall Market # 1184

Inventory Turnover Ratio Statistics
High Average Low
2.72 2.17 0.03
(Jun 30 2013)   (Dec 31 2023)




Financial Statements
Atrion's Inventories $ 68 Millions Visit ATRI's Balance sheet
Atrion's Cost of Revenues TTM $ 19 Millions Visit ATRI's Income Statement
What are ATRI's Sales? Visit ATRI's Sales by Segment

Other Inventory Turnover Ratios
Atrion's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ATRI's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ATRI's Competitors
Inventory Turnover Ratio for ATRI's Suppliers
Inventory Turnover Ratio for ATRI's Customers

You may also want to know
ATRI's Sales Growth Rates ATRI's Pe Price to earnings ratio ATRI's Receivables Turnover Ratio ATRI's Stock Quote
ATRI's Net Income Growth Rates ATRI's Ps Price to Sales ratio ATRI's Sales per Employee ATRI's Asset Turnover Ratio
ATRI's Net Margin ATRI's Pb Price to Book ratio ATRI's Financial Strength Ratios ATRI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2024 Inventories at quarter ending Jun 30 2024
60 Degrees Pharmaceuticals Inc   0.75 $ 0.372  Millions$ 0  Millions
Arcutis Biotherapeutics Inc   0.75 $ 10.148  Millions$ 14  Millions
Xeris Biopharma Holdings Inc   0.73 $ 29.532  Millions$ 40  Millions
Establishment Labs Holdings Inc   0.71 $ 50.555  Millions$ 71  Millions
Supernus Pharmaceuticals inc   0.71 $ 53.826  Millions$ 76  Millions
Amicus Therapeutics inc   0.70 $ 45.058  Millions$ 65  Millions
Petros Pharmaceuticals inc   0.69 $ 1.227  Millions$ 2  Millions
Aditxt Inc   0.69 $ 0.482  Millions$ 1  Millions
Delcath Systems Inc   0.68 $ 2.726  Millions$ 4  Millions
Scpharmaceuticals Inc   0.68 $ 6.937  Millions$ 10  Millions
Durect Corp  0.67 $ 1.615  Millions$ 2  Millions
Blueprint Medicines Corporation  0.66 $ 13.826  Millions$ 21  Millions
Hyperfine Inc   0.66 $ 4.652  Millions$ 7  Millions
Paragon 28 inc   0.65 $ 61.236  Millions$ 94  Millions
Butterfly Network Inc   0.64 $ 50.613  Millions$ 79  Millions
Vycor Medical Inc   0.62 $ 0.137  Millions$ 0  Millions
Lexicon Pharmaceuticals Inc   0.60 $ 0.274  Millions$ 0  Millions
Bioxcel Therapeutics Inc   0.60 $ 1.367  Millions$ 2  Millions
Macrogenics Inc   0.60 $ 0.694  Millions$ 1  Millions
Catheter Precision Inc   0.58 $ 0.034  Millions$ 0  Millions
Envoy Medical Inc   0.56 $ 0.821  Millions$ 1  Millions
Emmaus Life Sciences Inc   0.55 $ 0.903  Millions$ 2  Millions
Whitehawk Therapeutics Inc   0.55 $ 3.054  Millions$ 6  Millions
Cvrx inc   0.51 $ 5.672  Millions$ 11  Millions
Siga Technologies Inc  0.50 $ 31.237  Millions$ 62  Millions
Fennec Pharmaceuticals Inc   0.50 $ 1.016  Millions$ 2  Millions
Marinus Pharmaceuticals Inc   0.49 $ 1.946  Millions$ 4  Millions
Yubo International Biotech Limited  0.48 $ 0.087  Millions$ 0  Millions
Biomarin Pharmaceutical Inc  0.46 $ 515.862  Millions$ 1,115  Millions
Cyclo Therapeutics Inc   0.46 $ 0.110  Millions$ 0  Millions

Date modified: 2024-09-15T09:08:20+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.